ESR1 and urinary bladder carcinoma: In ERα-positive bladder cancer lines, E2 induced cell proliferation, while selective ER modulators, including tamoxifen and raloxifene, as well as a pure ER antagonist ICI 182,780, inhibited it [45,50,51].